Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05986032
Other study ID # REACT
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 15, 2023
Est. completion date September 24, 2024

Study information

Verified date March 2024
Source Fondazione IRCCS San Gerardo dei Tintori
Contact Camilla Rigotti, PhD
Phone +39039233
Email dr.camilla.rigotti@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about the correlation between respiratory system reactance, as assessed by respiratory oscillometry, and respiratory outcomes in preterm infants born before 32 weeks of gestation. The main question it aims to answer is if the reactance z-score at 7 postnatal days adds to relevant clinical factors in the prediction of bronchopulmonary dysplasia. Participants will receive respiratory oscillometry measurements at 7 ± 2 postnatal days.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date September 24, 2024
Est. primary completion date September 3, 2024
Accepts healthy volunteers No
Gender All
Age group 5 Days to 9 Days
Eligibility Inclusion Criteria: - born before 32 weeks post-menstrual age Exclusion Criteria: - congenital abnormalities - Inherited disorders of metabolism

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Respiratory Oscillometry
Measurement of respiratory system reactance by respiratory oscillometry

Locations

Country Name City State
Austria Medical University of Vienna Vienna Wien
Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano
Italy Fondazione IRCCS San Gerardo dei Tintori Monza Monza E Brianza
Netherlands Amsterdam UMC Amsterdam
Sweden Uppsala University Children's Hospital Uppsala
Switzerland Universitäts-Kinderspital beider Basel Basel

Sponsors (6)

Lead Sponsor Collaborator
Fondazione IRCCS San Gerardo dei Tintori Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Medical University of Vienna, University Children's Hospital Basel, Uppsala University Hospital

Countries where clinical trial is conducted

Austria,  Italy,  Netherlands,  Sweden,  Switzerland, 

References & Publications (2)

Veneroni C, Wallstrom L, Sindelar R, Dellaca' RL. Oscillatory respiratory mechanics on the first day of life improves prediction of respiratory outcomes in extremely preterm newborns. Pediatr Res. 2019 Feb;85(3):312-317. doi: 10.1038/s41390-018-0133-6. Epub 2018 Aug 4. — View Citation

Zannin E, Neumann RP, Dellaca R, Schulzke SM. Forced oscillation measurements in the first week of life and pulmonary outcome in very preterm infants on noninvasive respiratory support. Pediatr Res. 2019 Sep;86(3):382-388. doi: 10.1038/s41390-019-0432-6. Epub 2019 May 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Respiratory support mode Respiratory support mode will be coded as 0 = no respiratory support, 1 = nasal high flow therapy, 2 = nasal CPAP or nasal IPPV, 3 = invasive mechanical ventilation 7 postnatal days
Other Fraction of inspired oxygen 7 days of life
Primary Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure Xrs will be expressed in z-score using reference equation for very preterm infants Xrs will be measured at 7 days of life
Secondary Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure and ± 2 cmH2O Xrs will be expressed in cmH2O*S/L Xrs will be measured at 7 days of life
See also
  Status Clinical Trial Phase
Terminated NCT04506619 - Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Completed NCT04936477 - Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants N/A
Recruiting NCT05285345 - Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
Completed NCT03649932 - Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing Phase 1
Terminated NCT02524249 - Early Versus Late Caffeine for ELBW Newborns N/A
Completed NCT02249143 - Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants N/A
Active, not recruiting NCT01632475 - Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Unknown status NCT00254176 - Cysteine Supplementation in Critically Ill Neonates Phase 2/Phase 3
Completed NCT00419588 - Growth of Airways and Lung Tissues in Premature and Healthy Infants
Completed NCT00319956 - Trial II of Lung Protection With Azithromycin in the Preterm Infant Phase 2
Completed NCT00208039 - Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates N/A
Completed NCT00006401 - Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants Phase 3
Terminated NCT05030012 - Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants N/A
Completed NCT00006058 - Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns N/A
Completed NCT00005376 - Premature Birth and Its Sequelae in Women N/A
Completed NCT00011362 - Dexamethasone Therapy in VLBW Infants at Risk of CLD Phase 3
Completed NCT00004805 - Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death N/A
Completed NCT05152316 - The Baby Lung Study
Recruiting NCT04821453 - NAVA vs. CMV Crossover in Severe BPD N/A